Type 2 & other diabetes

Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real‐world observational study

Diabetes Obes MetabPublished Retrospective cohort study

Main finding · Macrovascular complications, age <65 yearsResult — go to the resultAdjusted hazard ratio 1.56 95% CI 1.08–2.26

Authors' conclusion

Those who had late intensification were at an increased risk of cardiovascular death if they were ≥65 years and an increased risk of macrovascular complications if they were <65 years. These findings highlight the critical need for earlier intensification of treatment and adopting personalized treatment strategies to improve patient outcomes.

Study context

Population
People with T2D initiated on basal insulin (BI); suboptimal glycaemia defined as HbA1c ≥7% (≥53 mmol/mol) within 12 months of BI initiationsuboptimal glycaemia
Participants
13,916 people
Exposure
Late (≥5 years) vs early (within 5 years) treatment intensification after BI initiation, each vs optimal glycaemia
Outcome
Micro- and macrovascular complications (age-stratified)
Methodological detailsreal-world, age-stratified
  • Real-world
  • Age-stratified

Main finding

Macrovascular complications, age <65 years

Adjusted hazard ratio

1.56

95% CI 1.08–2.26

Late intensificationvs Optimal glycaemia
aHR 1.56 (95% CI 1.08–2.26)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeEstimate
Cardiovascular-related death, age ≥65 yearsLate intensification vs Optimal glycaemia1.62 (CI 1.03–2.54)
Microvascular complications, age ≥65 yearsLate intensification vs Optimal glycaemia0.26 (CI 0.08–0.83)

No treatment intensification among those with suboptimal glycaemia

Did not receive any treatment intensification
52.5% (n = 7304)

Original publication

Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real‐world observational study. Diabetes Obes Metab. Published 19 October 2023. doi:10.1111/dom.15337

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.